Jennifer Ku to Bronchiectasis
This is a "connection" page, showing publications Jennifer Ku has written about Bronchiectasis.
Connection Strength
3.982
-
Tolerability Outcomes of American Thoracic Society/Infectious Diseases Society of America Guideline-Recommended Multidrug Antibiotic Treatment for Mycobacterium avium Complex Pulmonary Disease in US Medicare Beneficiaries With Bronchiectasis. Chest. 2024 May; 165(5):1058-1069.
Score: 0.913
-
Treatment of Nontuberculous Mycobacterial (NTM) Pulmonary Infection in the US Bronchiectasis and NTM Registry: Treatment Patterns, Adverse Events, and Adherence to American Thoracic Society/Infectious Disease Society of America Treatment Guidelines. Clin Infect Dis. 2023 01 13; 76(2):338-341.
Score: 0.858
-
Limited Validity of Diagnosis Code-based Claims to Identify Pseudomonas aeruginosa in Patients with Bronchiectasis in Medicare Data. Ann Am Thorac Soc. 2021 07; 18(7):1246-1249.
Score: 0.771
-
Validity of Diagnosis Code-Based Claims to Identify Pulmonary NTM Disease in Bronchiectasis Patients. Emerg Infect Dis. 2021 03; 27(3):982-985.
Score: 0.754
-
'Lady Windermere's counterpart? Pulmonary nontuberculous mycobacteria in men with bronchiectasis. Diagn Microbiol Infect Dis. 2020 Feb; 96(2):114916.
Score: 0.686